GEND - ETF AI Analysis
Top Page
Genter Capital Dividend Income ETF (GEND)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and over the last few months, indicating solid recent momentum.
Well-Performing Top Holdings
Most of the largest positions, including major health care, energy, and technology names, have delivered strong year-to-date returns that support the fund’s overall performance.
Broad Sector Diversification
The fund spreads its investments across many sectors such as health care, financials, energy, technology, and others, helping reduce the impact if any single industry struggles.
Negative Factors
Small Asset Base
The ETF manages a relatively small amount of money, which can make it more vulnerable to large investor inflows or outflows and may affect trading liquidity.
Higher-Than-Ultra-Low Fees
While not extremely expensive, the expense ratio is higher than the very cheapest index ETFs, slightly reducing the net return investors keep.
Heavy U.S. Concentration
Almost all of the fund’s holdings are in U.S. companies, offering little geographic diversification if the U.S. market faces a downturn.
GEND vs. SPDR S&P 500 ETF (SPY)
AUM5.05M
RegionNorth America
Expense Ratio0.38%
Beta0.47
IssuerGenter Capital
Inception DateJan 13, 2025
Dividend Yield2.58%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,156
30 Day Avg. Volume1,300
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
15.37Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering34
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GEND Summary
Genter Capital Dividend Income ETF (GEND) is a U.S.-focused fund that aims to deliver steady income by investing in companies that pay high, consistent dividends. It doesn’t track a specific index, but instead follows a dividend income theme across many sectors like health care, financials, energy, and technology. Well-known holdings include JPMorgan Chase, Chevron, Cisco Systems, CVS Health, and Merck. Someone might invest in GEND to add diversification and regular income to their portfolio. A key risk is that dividend-paying stocks can still fall in value and move up and down with the overall stock market.
How much will it cost me?The Genter Capital Dividend Income ETF (GEND) has an expense ratio of 0.38%, which means you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on selecting dividend-rich stocks rather than tracking a passive index. The higher cost reflects the additional research and management involved in curating its portfolio.
What would affect this ETF?The Genter Capital Dividend Income ETF (GEND) could benefit from stable economic conditions and low interest rates, which often support dividend-paying stocks, particularly in sectors like Health Care and Financials that make up a significant portion of its portfolio. However, rising interest rates or economic uncertainty could negatively impact dividend-focused investments, as companies may face challenges maintaining payouts. Additionally, sector-specific risks, such as regulatory changes in Health Care or volatility in Energy prices, could influence the ETF's performance.
GEND Top 10 Holdings
GEND leans heavily on classic U.S. dividend payers, with health care, financials, and energy doing much of the heavy lifting. Merck has been a standout, rising steadily and giving the fund a solid defensive anchor, while Devon Energy, Chevron, and Phillips 66 add punch as energy prices support their climb. Northern Trust, JPMorgan, and M&T Bank are generally helping, though their momentum is more measured. On the flip side, Accenture’s recent slide and CVS’s lagging share price are soft spots, reminding investors this income-focused mix isn’t immune to bumps.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Northern | 4.63% | $232.35K | $34.15B | 46.64% | 78 Outperform | |
| Accenture | 4.14% | $208.01K | $114.26B | -26.76% | 79 Outperform | |
| Merck & Company | 4.03% | $202.49K | $370.89B | 77.46% | 80 Outperform | |
| CVS Health | 4.01% | $201.22K | $123.73B | 31.12% | 64 Neutral | |
| Phillips 66 | 3.99% | $200.25K | $101.79B | 93.91% | 73 Outperform | |
| JPMorgan Chase | 3.97% | $199.40K | $953.33B | 21.83% | 72 Outperform | |
| Devon Energy | 3.93% | $197.48K | $52.87B | 38.26% | 79 Outperform | |
| Chevron | 3.88% | $194.62K | $412.15B | 35.75% | 71 Outperform | |
| Altria Group | 3.77% | $189.14K | $115.01B | 3.50% | 64 Neutral | |
| M&T Bank | 3.69% | $185.40K | $34.64B | 20.18% | 76 Outperform |
GEND Technical Analysis
Positive
―
Price Trends
13.21
Positive
12.91
Positive
12.40
Positive
Market Momentum
0.10
Positive
59.87
Neutral
74.87
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GEND, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 13.50, equal to the 50-day MA of 13.21, and equal to the 200-day MA of 12.40, indicating a bullish trend. The MACD of 0.10 indicates Positive momentum. The RSI at 59.87 is Neutral, neither overbought nor oversold. The STOCH value of 74.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GEND.
GEND Peer Comparison
Comparison Results
Performance Comparison
GEND
Genter Capital Dividend Income ETF
13.56
2.63
24.06%
PAYR
Federated Hermes Enhanced Income ETF
―
―
―
FDIV
MarketDesk Focused U.S. Dividend ETF
―
―
―
DIVY
Sound Equity Income ETF
―
―
―
VUS
Virtus US Dividend ETF
―
―
―
JHDV
John Hancock U.S. High Dividend ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents